Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012. http://globocan.iarc.fr. Accessed 20 Jan 2018.
Dominguez-Valentin M, Therkildsen C, Da Silva S, Nilbert M. Familial colorectal cancer type X: genetic profiles and phenotypic features. Mod Pathol. 2015;28:30–6.
Espenschied CR, LaDuca H, Li S, McFarland R, Gau C-L, Hampel H. Multigene panel testing provides a new perspective on Lynch syndrome. J Clin Oncol. 2017;35:2568–75.
Kurzawski G, Safranow K, Suchy J, Chlubek D, Scott RJ, Lubiński J. Mutation analysis of MLH1 and MSH2 genes performed by denaturing high-performance liquid chromatography. J Biochem Biophys Methods. 2002;51:89–100.
da Silva FC, de Oliveira Ferreira JR, Torrezan GT, Figueiredo MCP, Santos ÉMM, Nakagawa WT, et al. Clinical and molecular characterization of Brazilian patients suspected to have Lynch syndrome. PLoS One. 2015;10:e0139753.
Silva FCC, Valentin MD, Ferreira FO, Carraro DM, Rossi BM. Mismatch repair genes in Lynch syndrome: a review. Sao Paulo Med J. 2009;127:46–51.
Tutlewska K, Lubinski J, Kurzawski G. Germline deletions in the EPCAM gene as a cause of Lynch syndrome–literature review. Hered Cancer Clin Pract. 2013;11:9.
Aarnio M, Mecklin JP, Aaltonen LA, Nyström-Lahti M, Järvinen HJ. Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer. 1995;64:430–3.
Brosens LA, Offerhaus GJA, Giardiello FM. Hereditary colorectal cancer: genetics and screening. Surg Clin. 2015;95:1067–80.
Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med. 2005;352:1851–60.
Quehenberger F, Vasen H, Van Houwelingen H. Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment. J Med Genet. 2005;42:491–6.
Watson P, Vasen HF, Mecklin JP, Bernstein I, Aarnio M, Järvinen HJ, et al. The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome. Int J Cancer. 2008;123:444–9.
Pearlman R, Frankel WL, Swanson B, Zhao W, Yilmaz A, Miller K, et al. Prevalence and spectrum of germline cancer susceptibility gene mutations among patients with early-onset colorectal cancer. JAMA Oncol. 2017;3:464–71.
Vasen H, Mecklin J, Khan P, Lynch H. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum. 1991;34:424.
Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the international collaborative group on HNPCC. Gastroenterology. 1999;116:1453–6.
Shia J. Evolving approach and clinical significance of detecting DNA mismatch repair deficiency in colorectal carcinoma. Semin Diagn Pathol. 2015;32:352–61.
Palomaki GE, McClain MR, Melillo S, Hampel HL, Thibodeau SN. EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome. Genet Med. 2009;11:42.
Kladny J, Lubiñski J. Lynch syndrome (HNPCC). Hered Cancer Clin Pract. 2008;6:99–102.
Park J-G, Vasen HF, Park KJ, Peltomaki P, De Leon MP, Rodriguez-Bigas MA, et al. Suspected hereditary nonpolyposis colorectal cancer. Dis Colon Rectum. 1999;42:710–5.
Park J-G, Vasen HF, Park Y, Park K, Peltomaki P, De Leon MP, et al. Suspected HNPCC and Amsterdam criteria II: evaluation of mutation detection rate, an international collaborative study. Int J Color Dis. 2002;17:109–14.
Caldes T, Godino J, De La Hoya M, Garcia Carbonero I, Perez Segura P, Eng C, et al. Prevalence of germline mutations of MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer families from Spain. Int J Cancer. 2002;98:774–9.
Nyström-Lahti M, Wu Y, Moisio A-L, Hofstra RM, Osinga J, Mecklin J-P, et al. DNA mismatch repair gene mutations in 55 kindreds with verified or putative hereditary non-polyposis colorectal cancer. Hum Mol Genet. 1996;5:763–9.
Tannergård P, Lipford JR, Kolodner R, Frödin JE, Nordenskjöld M, Lindblom A. Mutation screening in the hMLH1 gene in Swedish hereditary nonpolyposis colon cancer families. Cancer Res. 1995;55:6092–6.
Rashid MU, Muzaffar M, Khan FA, Kabisch M, Muhammad N, Faiz S, et al. Association between the BsmI polymorphism in the vitamin D receptor gene and breast cancer risk: results from a Pakistani case-control study. PLoS One. 2015;10:e0141562.
Kolodner RD, Tytell JD, Schmeits JL, Kane MF, Gupta RD, Weger J, et al. Germ-line msh6 mutations in colorectal cancer families. Cancer Res. 1999;59:5068–74.
Rashid MU, Muhammad N, Faisal S, Amin A, Hamann U. Deleterious RAD51C germline mutations rarely predispose to breast and ovarian cancer in Pakistan. Breast Cancer Res Treat. 2014;145:775–84.
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.
Rashid MU, Naeemi H, Muhammad N, Loya A, Yusuf MA, Lubiński J, et al. A novel deleterious c. 2656G> T MSH2 germline mutation in a Pakistani family with a phenotypic overlap of hereditary breast and ovarian cancer and Lynch syndrome. Hered Cancer Clin Pract. 2016;14:14.
Hardt K, Heick SB, Betz B, Goecke T, Yazdanparast H, Kuppers R, et al. Missense variants in hMLH1 identified in patients from the German HNPCC consortium and functional studies. Familial Cancer. 2011;10:273–84.
Barnetson RA, Tenesa A, Farrington SM, Nicholl ID, Cetnarskyj R, Porteous ME, et al. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med. 2006;354:2751–63.
Dymerska D, Kurzawski G, Suchy J, Roomere H, Toome K, Metspalu A, et al. Lynch syndrome mutations shared by the Baltic States and Poland. Clin Genet. 2014;86:190–3.
Kurzawski G, Suchy J, Lener M, Kłujszo-Grabowska E, Kładny J, Safranow K, et al. Germline MSH2 and MLH1 mutational spectrum including large rearrangements in HNPCC families from Poland (update study). Clin Genet. 2006;69:40–7.
Mangold E, Pagenstecher C, Friedl W, Mathiak M, Buettner R, Engel C, et al. Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1,721 German families suspected of hereditary nonpolyposis colorectal cancer. Int J Cancer. 2005;116:692–702.
Nilbert M, Wikman FP, Hansen TV, Krarup HB, Örntoft TF, Nielsen FC, et al. Major contribution from recurrent alterations and MSH6 mutations in the Danish Lynch syndrome population. Familial Cancer. 2009;8:75–83.
Sheng J-Q, Zhang H, Ji M, Fu L, Mu H, Zhang M-Z, et al. Genetic diagnosis strategy of hereditary non-polyposis colorectal cancer. World J Gastroenterol: WJG. 2009;15:983.
Sjursen W, McPhillips M, Scott RJ, Talseth-Palmer BA. Lynch syndrome mutation spectrum in New South Wales, Australia, including 55 novel mutations. Mol Genet Genomic Med. 2016;4:223–31.
Pedroni M, Roncari B, Maffei S, Losi L, Scarselli A, Di Gregorio C, et al. A mononucleotide markers panel to identify hMLH1/hMSH2 germline mutations. Dis Markers. 2007;23:179–87.
Ollila S, Dermadi Bebek D, Jiricny J, Nyström M. Mechanisms of pathogenicity in human MSH2 missense mutants. Hum Mutat. 2008;29:1355–63.
Lee SY, Kim DW, Shin YK, Ihn MH, Lee SM, Oh HK, et al. Validation of prediction models for mismatch repair gene mutations in Koreans. Cancer Res Treat. 2016;48:668–75.
Liu Y, Chew MH, Goh XW, Tan SY, Loi CTT, Tan YM, et al. Systematic study on genetic and epimutational profile of a cohort of Amsterdam criteria-defined Lynch syndrome in Singapore. PLoS One. 2014;9:e94170.
Zhang J-X, Fu L, de Voer RM, Hahn M-M, Jin P, Lv C-X, et al. Candidate colorectal cancer predisposing gene variants in Chinese early-onset and familial cases. World J Gastroenterol: WJG. 2015;21:4136.
Mueller J, Gazzoli I, Bandipalliam P, Garber JE, Syngal S, Kolodner RD. Comprehensive molecular analysis of mismatch repair gene defects in suspected Lynch syndrome (hereditary nonpolyposis colorectal cancer) cases. Cancer Res. 2009;69:7053–61.
Kamiza AB, Hsieh L-L, Tang R, Chien H-T, Lai C-H, Chiu L-L, et al. Risk factors associated with colorectal cancer in a subset of patients with mutations in MLH1 and MSH2 in Taiwan fulfilling the Amsterdam II criteria for Lynch syndrome. PLoS One. 2015;10:e0130018.
Yan S-Y, Zhou X-Y, Du X, Zhang T-M, Lu Y-M, Cai S-J, et al. Three novel missense germline mutations in different exons of MSH6 gene in Chinese hereditary non-polyposis colorectal cancer families. World J Gastroenterol: WJG. 2007;13:5021.
Peltomäki P, Vasen H. Mutations associated with HNPCC predisposition—update of ICG-HNPCC/INSiGHT mutation database. Dis Markers. 2004;20:269–76.
Tunca B, Pedroni M, Cecener G, Egeli U, Borsi E, Zorluoglu A, et al. Analysis of mismatch repair gene mutations in Turkish HNPCC patients. Familial Cancer. 2010;9:365–76.
Cruz-Correa M, Diaz-Algorri Y, Pérez-Mayoral J, Suleiman-Suleiman W, del Mar G-PM, Bertrán C, et al. Clinical characterization and mutation spectrum in Caribbean Hispanic families with Lynch syndrome. Familial Cancer. 2015;14:415–25.
Suzuki O, Eguchi H, Chika N, Sakimoto T, Ishibashi K, Kumamoto K, et al. Prevalence and clinicopathologic/molecular characteristics of mismatch repair-deficient colorectal cancer in the under-50-year-old Japanese population. Surg Today. 2017;47:1135–46.
Hu F, Li D, Wang Y, Yao X, Zhang W, Liang J, et al. Novel DNA variants and mutation frequencies of hMLH1 and hMSH2 genes in colorectal cancer in the Northeast China population. PLoS One. 2013;8:e60233.